Technology
Health
Medical

Verona Pharma

129

$3.82
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.20 (-4.98%) Today
$0.00 (0.00%) As of 6:00 PM EST after-hours

Why Robinhood?

You can buy or sell Verona Pharma and other stocks, options, ETFs, and crypto commission-free!

About VRNA

Verona Pharma Plc operates as a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases. It's product include, RPL554, is a dual inhibitor of the enzymes phosphodiesterase 3 and 4 that acts as both a bronchodilator and an anti-inflammatory agent in a single compound. Read More The firm develops RPL554 for the treatment of chronic obstructive pulmonary disease (COPD), cystic fibrosis, and potentially asthma. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, United Kingdom.

CEO
Jan-Anders Karlsson
Employees
—
Headquarters
London, Greater London
Founded
2005
Market Cap
60.27M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
34.55K
High Today
$4.01
Low Today
$3.76
Open Price
$4.00
Volume
23.29K
52 Week High
$11.04
52 Week Low
$3.65

Collections

Technology
Health
Medical
Biopharmaceutical
Therapy
Pharmaceutical
2017 IPO
UK

VRNA Earnings

-$0.79
-$0.52
-$0.26
$0.01
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Feb 25, Pre-Market

You May Also Like

VAL
CEPU
BNKU
EZJ
AXTA
VALU
DBSDY
FHK
AGNCM
LEE
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy VRNA

Market Price$3.82
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Verona Pharma stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up